Literature DB >> 9096674

Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.

A Stahl1, B M Mueller.   

Abstract

Tumor cell migration and invasion require complex interactions between tumor cells and the surrounding extracellular matrix. These interactions are modified by cell adhesion receptors, as well as by proteolytic enzymes and their receptors. Here, we study the influence of the protease urokinasetype plasminogen activator (uPA) and its receptor (uPAR) on melanoma cell adhesion to, and migration on, the extracellular matrix protein vitronectin (VN). Cell adhesion to VN, but not to type I collagen, is significantly enhanced in the presence of either uPA or its amino-terminal fragment (ATF). Soluble uPAR can inhibit this effect, indicating that uPA/uPAR on melanoma cells can function as a VN receptor. In the absence of bivalent cations, uPA/uPAR can promote cell attachment on VN, but not cell spreading, suggesting that the glycosylphosphatidylinositol (GPI)-anchored uPAR alone is unable to organize the cytoskeleton. Chemotactic melanoma cell migration on a uniform VN matrix is inhibited by uPA and ATF, implying that cell motility decreases when uPA/uPAR acts as a VN receptor. In contrast, plasminogen activator inhibitor I (PAI-I) can stimulate melanoma cell migration on VN, presumably by inhibiting uPA/uPAR-mediated cell adhesion to VN and thereby releasing the inhibition of cell migration induced by uPA. Together, our data implicate components of the plasminogen activation system in the direct regulation of cell adhesion and migration, thereby modulating the behavior of malignant tumor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096674     DOI: 10.1002/(sici)1097-0215(19970328)71:1<116::aid-ijc19>3.0.co;2-g

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  TGF-β-induced intracellular PAI-1 is responsible for retaining hematopoietic stem cells in the niche.

Authors:  Takashi Yahata; Abd Aziz Ibrahim; Yukari Muguruma; Mesut Eren; Alexander M Shaffer; Nobuo Watanabe; Satoko Kaneko; Tetsuo Nakabayashi; Takashi Dan; Noriaki Hirayama; Douglas E Vaughan; Toshio Miyata; Kiyoshi Ando
Journal:  Blood       Date:  2017-08-18       Impact factor: 22.113

2.  Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

Authors:  Bénédicte Chazaud; Rémy Ricoux; Christo Christov; Anne Plonquet; Romain K Gherardi; Georgia Barlovatz-Meimon
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.

Authors:  Henrik Gårdsvoll; Benedikte Jacobsen; Mette C Kriegbaum; Niels Behrendt; Lars Engelholm; Søren Østergaard; Michael Ploug
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

4.  alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.

Authors:  A Lochter; M Navre; Z Werb; M J Bissell
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

5.  Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase.

Authors:  Susan G Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

6.  siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.

Authors:  Ramesh Subramanian; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Jasti S Rao
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

7.  Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.

Authors:  Hyejin Jeon; Jong-Heon Kim; Jae-Hong Kim; Won-Ha Lee; Myung-Shik Lee; Kyoungho Suk
Journal:  J Neuroinflammation       Date:  2012-06-29       Impact factor: 8.322

8.  Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.

Authors:  L Kjøller; A Hall
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

9.  Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.

Authors:  M Weinmann; O Thews; T Schroeder; P Vaupel
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

10.  The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis.

Authors:  George Perides; Yuzheng Zhuge; Tina Lin; Monique F Stins; Roderick T Bronson; Julian K Wu
Journal:  BMC Cancer       Date:  2006-03-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.